Navigation Links
FASEB SRC announces conference: Renal Hemodynamics: Integrating with the Nephron & Beyond
Date:2/4/2013

Bethesda, MD The Federation of American Societies for Experimental Biology (FASEB) announces the opening of registration for the Science Research Conference (SRC): Renal Hemodynamics: Integrating with the Nephron and Beyond.

The 2013 FASEB Science Research Conference on "Renal Hemodynamics: Integrating with the Nephron and Beyond" is an important and unique scientific conference that will focus on presentation and discussion of the latest research findings in the area of renal hemodynamic mechanisms that are the cause and consequence of a wide range of disorders including hypertension, diabetes, obesity, metabolic syndrome, glomerular sclerosis and nephropathy.

Held every three years, the 2013 conference format is designed to facilitate presentation and discussion of unpublished research and maximum exchange of novel ideas and hypotheses. The informal setting allows the latest cutting edge research to be used to further our understanding of the physiology and pathophysiology of the kidney.

FASEB SRC has announced a total of 34 SRCs in 2013. To register for an SRC, view preliminary programs, or find a listing of all our 2013 SRCs, please visit www.faseb.org/SRC.


'/>"/>

Contact: Robin Crawford
src@faseb.org
301-634-7010
Federation of American Societies for Experimental Biology
Source:Eurekalert

Page: 1

Related biology news :

1. FASEB SRC announces: Mechanism and Regulation of Prokaryotic Transcription Conference
2. FASEB SRC announces conference registration open: The Biology of Calpains in Health and Disease
3. FASEB SRC announces conference: Gastrointestinal Tract XV: Epithelia, Microbes, Inflammation & Cancer
4. FASEB urges biomedical research community to speak out against sequestration
5. FASEB lauds Air India for transporting research animals
6. Undergraduate Student Summer Research Award recipients announced for the 2012 FASEB MARC summer research opportunity program
7. FASEB 2013 Excellence in Science Award recipient announced
8. Elsevier announces the launch of a new journal: Anthropocene
9. Biophysical Society announces 2013 New and Notable Symposium speakers
10. Biophysical Society announces winners of 2013 international travel awards
11. Biophysical Society announces winners of 2013 Education Committee travel awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/15/2016)... 2016 Research and Markets has ... Market 2016-2020,"  report to their offering.  , ... ,The global gait biometrics market is expected to ... period 2016-2020. Gait analysis generates multiple ... used to compute factors that are not or ...
(Date:3/31/2016)... BOCA RATON, Florida , March 31, 2016 /PRNewswire/ ... LEGX ) ("LegacyXChange" or the "Company") ... presentation for potential users of its soon to be ... The video ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also ... by the use of DNA technology to an industry ...
(Date:3/23/2016)... Massachusetts , March 23, 2016 /PRNewswire/ ... im Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung ... Xura, Inc. (NASDAQ: MESG ), ... bekannt, dass das Unternehmen mit SpeechPro zusammenarbeitet, ... aus der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial ... Cary 5000 and the 6000i models are higher end machines that use the more ... the spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)...  The Biodesign Challenge (BDC), a university competition that ... living systems and biotechnology, announced its winning teams at ... New York City . The teams, ... at MoMA,s Celeste Bartos Theater during the daylong summit. ... curator of architecture and design, and Suzanne Lee ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: